Report Detail

Other Global Oncology Small Molecule Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3811420
  • |
  • 10 October, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Table of Contents

    1 Oncology Small Molecule Drugs Market Overview

    • 1.1 Product Overview and Scope of Oncology Small Molecule Drugs
    • 1.2 Classification of Oncology Small Molecule Drugs by Types
      • 1.2.1 Global Oncology Small Molecule Drugs Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Oncology Small Molecule Drugs Revenue Market Share by Types in 2018
      • 1.2.3 Chemotherapy Drugs
      • 1.2.4 Immunomodulating Drugs
      • 1.2.5 Targeted Therapy Drugs
      • 1.2.6 Hormonal Therapy
      • 1.2.7 Other
    • 1.3 Global Oncology Small Molecule Drugs Market by Application
      • 1.3.1 Global Oncology Small Molecule Drugs Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Blood Cancer
      • 1.3.3 Breast Cancer
      • 1.3.4 Gastrointestinal Cancer
      • 1.3.5 Prostate Cancer
      • 1.3.6 Lung Cancer
      • 1.3.7 Other
    • 1.4 Global Oncology Small Molecule Drugs Market by Regions
      • 1.4.1 Global Oncology Small Molecule Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Oncology Small Molecule Drugs (2014-2024)

    2 Company Profiles

    • 2.1 Johnson & Johnson
      • 2.1.1 Business Overview
      • 2.1.2 Oncology Small Molecule Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Johnson & Johnson Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 AbbVie
      • 2.2.1 Business Overview
      • 2.2.2 Oncology Small Molecule Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 AbbVie Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Celgene
      • 2.3.1 Business Overview
      • 2.3.2 Oncology Small Molecule Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Celgene Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Novartis
      • 2.4.1 Business Overview
      • 2.4.2 Oncology Small Molecule Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Novartis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Roche
      • 2.5.1 Business Overview
      • 2.5.2 Oncology Small Molecule Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Roche Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Pfizer
      • 2.6.1 Business Overview
      • 2.6.2 Oncology Small Molecule Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Pfizer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Takeda
      • 2.7.1 Business Overview
      • 2.7.2 Oncology Small Molecule Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Takeda Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Amgen
      • 2.8.1 Business Overview
      • 2.8.2 Oncology Small Molecule Drugs Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Amgen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Bristol-Myers Squibb
      • 2.9.1 Business Overview
      • 2.9.2 Oncology Small Molecule Drugs Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Sanofi
      • 2.10.1 Business Overview
      • 2.10.2 Oncology Small Molecule Drugs Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Sanofi Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Merck
      • 2.11.1 Business Overview
      • 2.11.2 Oncology Small Molecule Drugs Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Merck Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Teva
      • 2.12.1 Business Overview
      • 2.12.2 Oncology Small Molecule Drugs Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Teva Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Eli Lilly
      • 2.13.1 Business Overview
      • 2.13.2 Oncology Small Molecule Drugs Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Eli Lilly Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Ipsen
      • 2.14.1 Business Overview
      • 2.14.2 Oncology Small Molecule Drugs Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Ipsen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Biogen Idec
      • 2.15.1 Business Overview
      • 2.15.2 Oncology Small Molecule Drugs Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Biogen Idec Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Astellas
      • 2.16.1 Business Overview
      • 2.16.2 Oncology Small Molecule Drugs Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Astellas Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 Bayer
      • 2.17.1 Business Overview
      • 2.17.2 Oncology Small Molecule Drugs Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 Bayer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 Otsuka
      • 2.18.1 Business Overview
      • 2.18.2 Oncology Small Molecule Drugs Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 Otsuka Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 Eisai
      • 2.19.1 Business Overview
      • 2.19.2 Oncology Small Molecule Drugs Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 Eisai Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 AstraZeneca
      • 2.20.1 Business Overview
      • 2.20.2 Oncology Small Molecule Drugs Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 AstraZeneca Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.21 Gilead Sciences
      • 2.21.1 Business Overview
      • 2.21.2 Oncology Small Molecule Drugs Type and Applications
        • 2.21.2.1 Product A
        • 2.21.2.2 Product B
      • 2.21.3 Gilead Sciences Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.22 Exelixis
      • 2.22.1 Business Overview
      • 2.22.2 Oncology Small Molecule Drugs Type and Applications
        • 2.22.2.1 Product A
        • 2.22.2.2 Product B
      • 2.22.3 Exelixis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Oncology Small Molecule Drugs Market Competition, by Players

    • 3.1 Global Oncology Small Molecule Drugs Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Oncology Small Molecule Drugs Players Market Share
      • 3.2.2 Top 10 Oncology Small Molecule Drugs Players Market Share
    • 3.3 Market Competition Trend

    4 Global Oncology Small Molecule Drugs Market Size by Regions

    • 4.1 Global Oncology Small Molecule Drugs Revenue and Market Share by Regions
    • 4.2 North America Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 4.5 South America Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)

    5 North America Oncology Small Molecule Drugs Revenue by Countries

    • 5.1 North America Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
    • 5.2 USA Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)

    6 Europe Oncology Small Molecule Drugs Revenue by Countries

    • 6.1 Europe Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
    • 6.2 Germany Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 6.3 UK Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 6.4 France Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Oncology Small Molecule Drugs Revenue by Countries

    • 7.1 Asia-Pacific Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
    • 7.2 China Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 7.5 India Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)

    8 South America Oncology Small Molecule Drugs Revenue by Countries

    • 8.1 South America Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
    • 8.2 Brazil Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Oncology Small Molecule Drugs by Countries

    • 9.1 Middle East and Africa Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)

    10 Global Oncology Small Molecule Drugs Market Segment by Type

    • 10.1 Global Oncology Small Molecule Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Oncology Small Molecule Drugs Market Forecast by Type (2019-2024)
    • 10.3 Chemotherapy Drugs Revenue Growth Rate (2014-2024)
    • 10.4 Immunomodulating Drugs Revenue Growth Rate (2014-2024)
    • 10.5 Targeted Therapy Drugs Revenue Growth Rate (2014-2024)
    • 10.6 Hormonal Therapy Revenue Growth Rate (2014-2024)
    • 10.7 Other Revenue Growth Rate (2014-2024)

    11 Global Oncology Small Molecule Drugs Market Segment by Application

    • 11.1 Global Oncology Small Molecule Drugs Revenue Market Share by Application (2014-2019)
    • 11.2 Oncology Small Molecule Drugs Market Forecast by Application (2019-2024)
    • 11.3 Blood Cancer Revenue Growth (2014-2019)
    • 11.4 Breast Cancer Revenue Growth (2014-2019)
    • 11.5 Gastrointestinal Cancer Revenue Growth (2014-2019)
    • 11.6 Prostate Cancer Revenue Growth (2014-2019)
    • 11.7 Lung Cancer Revenue Growth (2014-2019)
    • 11.8 Other Revenue Growth (2014-2019)

    12 Global Oncology Small Molecule Drugs Market Size Forecast (2019-2024)

    • 12.1 Global Oncology Small Molecule Drugs Market Size Forecast (2019-2024)
    • 12.2 Global Oncology Small Molecule Drugs Market Forecast by Regions (2019-2024)
    • 12.3 North America Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
    • 12.4 Europe Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
    • 12.6 South America Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Scope of the Report:
      The global Oncology Small Molecule Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oncology Small Molecule Drugs.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Oncology Small Molecule Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oncology Small Molecule Drugs market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Johnson & Johnson
      AbbVie
      Celgene
      Novartis
      Roche
      Pfizer
      Takeda
      Amgen
      Bristol-Myers Squibb
      Sanofi
      Merck
      Teva
      Eli Lilly
      Ipsen
      Biogen Idec
      Astellas
      Bayer
      Otsuka
      Eisai
      AstraZeneca
      Gilead Sciences
      Exelixis

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Chemotherapy Drugs
      Immunomodulating Drugs
      Targeted Therapy Drugs
      Hormonal Therapy
      Other

      Market Segment by Applications, can be divided into
      Blood Cancer
      Breast Cancer
      Gastrointestinal Cancer
      Prostate Cancer
      Lung Cancer
      Other


      Summary:
      Get latest Market Research Reports on Oncology Small Molecule Drugs. Industry analysis & Market Report on Oncology Small Molecule Drugs is a syndicated market report, published as Global Oncology Small Molecule Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Oncology Small Molecule Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,724.10
      4,086.14
      5,448.19
      3,150.80
      4,726.20
      6,301.60
      378,484.80
      567,727.20
      756,969.60
      248,715.95
      373,073.92
      497,431.90
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report